Michael VanSaun, PhD

Home Research Research Grants Program Grants Awarded Grants Awarded by Year 2008 Research Grants Michael VanSaun, PhD


Institution: Vanderbilt University
Research Project: Influence of Adipokines on Pancreatic Cancer Progression
Award: Pancreatic Cancer Action Network – AACR Career Development Award
Award Period: July 1, 2010 – June 30, 2012
Amount: $200,000

Click here to download Dr. VanSaun’s Grant Snapshot (pdf)

Biographical Highlights
Dr. VanSaun received his PhD in Anatomy and Cell Biology from the University of Kansas Medical Center in 2003. He then joined Vanderbilt University in 2004 as a Research Fellow, first completing his postdoctoral training in the Department of Cancer Biology, and then advancing to a Research Instructor in the Departments of Surgery and Cancer Biology in 2009. Through his involvement with the Division of Hepatobiliary Surgery and Liver Transplantation at Vanderbilt, Dr. VanSaun has become acutely aware of the struggle faced by pancreatic cancer patients. His interest in pancreatic cancer research also has been sparked by personal circumstances as there have been multiple gastrointestinal related cancers in his family. Dr. VanSaun hopes to identify novel molecular mediators of pancreatic cancer progression and determine their potential for prevention and/or therapeutics. His research contributions have been published in several leading scientific journals, including American Journal of Pathology, Cancer Research, Molecular Imaging, Developmental Neurobiology, Molecular and Cellular Biology, and Journal of Neurobiology.

Project Overview
Research has shown a link between obesity and increased inflammation and pancreatitis, as well as a potential increased rate of pancreatic cancer. Dr. VanSaun previously identified a category of proteins, called adipokines, that are derived by adipose (fat) tissue, and can act upon the tumor cells, potentially influencing their growth. Consistent with this possibility, Dr. VanSaun has discovered the expression of the appropriate receptors that bind and are activated by these adipokines on the pancreatic cancer cell surface.

The purpose of this project is to determine the role of adipokines, and obesity in general, on pancreatic cancer development and progression. First, Dr. VanSaun and colleagues will analyze pancreatic cancer cells cultured in a dish, with genetically altered receptors for these adipokines. He hypothesizes that the absence of functional adipokine receptors will yield cancer cells with reduced ability to grow, move, and penetrate cell membranes. Next, Dr. VanSaun will conduct similar experiments in a mouse model, assessing whether a deficiency of functional adipokine receptors will affect the tumors’ growth in the mouse. He will also analyze the effects of a high-fat diet on the ability of pancreatic tumors to grow and develop in mice. Overall, these important studies will shed light on the interconnection between obesity, fat-derived factors, and pancreatic cancer.

Wage Hope With Us

Join us to make a difference for pancreatic cancer patients.

shop purple logo

Gear, apparel, accessories and more to show off your purple pride.

Shop Now 

©2020 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy

Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.

The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.